MDXH(MDXH)
MDXH
ANALYST COVERAGE6 analysts
BUY
▲ +400.0%upside to target
Key MetricsTTM
Market Cap$41.09M
Revenue TTM$171.32M
Net Income TTM-$64.22M
Free Cash Flow-$22.33M
Gross Margin57.7%
Operating Margin-16.6%
Net Margin-32.2%
Return on Equity403.0%
Return on Assets-17.7%
Debt / Equity-7.86
Current Ratio1.08
EPS TTM$-0.52
PRICE
Prev Close
0.83
Open
0.83
Day Range0.80 – 0.84
0.80
0.84
52W Range0.68 – 5.33
0.68
5.33
3% of range
VOLUME & SIZE
Avg Volume
460.4K
FUNDAMENTALS
P/E Ratio
-1.2x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
TECHNICAL
RSI (14)
17
Oversold
Upcoming Events
EEarnings Report
Tomorrow
May 23
DEx-Dividend
In 90 days
Aug 20
PDividend Pay
In 119 days
Sep 18
MDXH News
About
No description available.
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Michael McGarrity
Country
Belgium
Website
Kim LerouxExecutive Vice President of Revenue Cycle Management
Miriam ReyesExecutive Vice President of Operations
Michael K. McGarrityChief Executive Officer & Executive Director
Scott McMahanVice President of Finance and Accounting
John A. BellanoChief Commercial Officer
Joseph SolleeExecutive Vice President of Corporate Development & General Counsel
Ron KalfusInterim Chief Financial Officer